Paul S. Williams
Fondateur chez Heflin & Williams, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Sunder H. Malkani | M | - |
OcuCure Therapeutics, Inc.
 OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Stephen M. Martin | M | 77 |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Patricia B. Williams | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Craig M. Greven | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| W. Ben Deibler | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Richard M. Haugen | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Dan H. Heflin | M | - |
Heflin & Williams, Inc.
 Heflin & Williams, Inc. Miscellaneous Commercial ServicesCommercial Services Heflin & Williams, Inc. provides business management consulting services. It offers litigation and support, project management, contract management, cost estimating, and consultancy. The company was founded by Dan H. Heflin, Jr. and Paul S. Williams in 1992 and is headquartered in Norfolk, VA. | 32 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 7 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Paul S. Williams
- Réseau Personnel
